iproniazid has been researched along with Myocarditis in 1 studies
Myocarditis: Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MOND, E | 1 |
| MACK, I | 1 |
1 other study available for iproniazid and Myocarditis
| Article | Year |
|---|---|
Cardiac toxicity of iproniazid (marsilid): report of myocardial injury in a patient receiving levarterenol.
Topics: Cardiotoxicity; Humans; Iproniazid; Myocarditis; Norepinephrine | 1960 |